Paper · 11090108
Inhibitory effects of JTV-519, a novel cardioprotective drug, on potassium currents and experimental atrial fibrillation in guinea-pig hearts.
Nakaya H and 4 others. Br J Pharmacol, 2000. Cited by 48 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Inhibitory effects of JTV-519, a novel cardioprotective drug, on potassium currents and experimental atrial fibrillation in guinea-pig hearts. Papers, record 11090108. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/11090108
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Inhibitory effects of JTV-519, a novel cardioprotective drug, on potassium currents and experimental atrial fibrillation in guinea-pig hearts.
- PubMed
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Atrial Fibrillation | Major topic |
| Cardiovascular Agents | Major topic |
| Heart | Major topic |
| Membrane Potentials | Major topic |
| Potassium Channels | Major topic |
| Thiazepines | Major topic |
| Action Potentials | |
| Adenosine | |
| Animals | |
| Atrial Function | |
| Calcium Channel Blockers | |
| Carbachol | |
| Dose-Response Relationship, Drug | |
| Guanosine 5'-O-(3-Thiotriphosphate) | |
| Guinea Pigs | |
| Heart Atria | |
| In Vitro Techniques | |
| Receptors, Muscarinic |
Source PubMed
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References38
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 10,588,929 | Bepridil differentially inhibits two delayed rectifier K(+) currents, I(Kr) and I(Ks), in guinea-pig ventricular myocytes. | Br J Pharmacol | 1999 | https://conductscience.org/library/papers/10588929 | PubMed |
| 2 | 8,417,848 | Rate-dependent prolongation of cardiac action potentials by a methanesulfonanilide class III antiarrhythmic agent. Specific block of rapidly activating delayed rectifier K+ current by dofetilide. | Circ Res | 1993 | https://conductscience.org/library/papers/8417848 | PubMed |
| 3 | 10,683,355 | Anti-ischemic effect of a novel cardioprotective agent, JTV519, is mediated through specific activation of delta-isoform of protein kinase C in rat ventricular myocardium. | Circulation | 2000 | https://conductscience.org/library/papers/10683355 | PubMed |
| 4 | 10,704,162 | Acute myocardial infarction complicated by atrial fibrillation in the elderly: prevalence and outcomes. | Circulation | 2000 | https://conductscience.org/library/papers/10704162 | PubMed |
| 5 | 533,865 | Calculator programs for computing the composition of the solutions containing multiple metals and ligands used for experiments in skinned muscle cells. | J Physiol (Paris) | 1979 | https://conductscience.org/library/papers/533865 | PubMed |
| 6 | 8,428,201 | Antiarrhythmic agents act differently on the activation phase of the ACh-response in guinea-pig atrial myocytes. | Br J Pharmacol | 1993 | https://conductscience.org/library/papers/8428201 | PubMed |
| 7 | 7,684,298 | Effects of MS-551, a new class III antiarrhythmic drug, on action potential and membrane currents in rabbit ventricular myocytes. | Br J Pharmacol | 1993 | https://conductscience.org/library/papers/7684298 | PubMed |
| 8 | 7,516,012 | Molecular mechanism of cibenzoline-induced anticholinergic action in single atrial myocytes: comparison with effect of disopyramide. | J Cardiovasc Pharmacol | 1994 | https://conductscience.org/library/papers/7516012 | PubMed |
| 9 | 7,528,835 | Effects of E-4031 on atrial fibrillation threshold in guinea pig atria: comparative study with class I antiarrhythmic drugs. | J Cardiovasc Pharmacol | 1994 | https://conductscience.org/library/papers/7528835 | PubMed |
| 10 | 7,758,191 | Anticholinergic effects of class III antiarrhythmic drugs in guinea pig atrial cells. Different molecular mechanisms. | Circulation | 1995 | https://conductscience.org/library/papers/7758191 | PubMed |
1 to 10 of 38
See all 38 referencesCited by17
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 48 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41,389,127 | Crosstalk between Ryanodine Receptor 2 Dysfunction and FK506-Binding Proteins in Pulmonary Hypertension. | Cardiovasc Drugs Ther | 2026 | https://conductscience.org/library/papers/41389127 | PubMed |
| 40,768,812 | Pharmacological study of the safety, efficacy, and potential of M201-A on paroxysmal and persistent atrial fibrillation. | J Pharmacol Exp Ther | 2025 | https://conductscience.org/library/papers/40768812 | PubMed |
| 36,625,865 | Role of ryanodine receptor 2 and FK506-binding protein 12.6 dissociation in pulmonary hypertension. | J Gen Physiol | 2023 | https://conductscience.org/library/papers/36625865 | PubMed |
| 31,607,952 | Differential Modulation of IK and ICa,L Channels in High-Fat Diet-Induced Obese Guinea Pig Atria. | Front Physiol | 2019 | https://conductscience.org/library/papers/31607952 | PubMed |
| 28,596,175 | Calcium Signaling and Cardiac Arrhythmias. | Circ Res | 2017 | https://conductscience.org/library/papers/28596175 | PubMed |
| 28,181,690 | Calcium-mediated cellular triggered activity in atrial fibrillation. | J Physiol | 2017 | https://conductscience.org/library/papers/28181690 | PubMed |
| 24,733,689 | New antiarrhythmic targets to control intracellular calcium handling. | Neth Heart J | 2014 | https://conductscience.org/library/papers/24733689 | PubMed |
| 22,932,727 | The ryanodine receptor leak: how a tattered receptor plunges the failing heart into crisis. | Heart Fail Rev | 2013 | https://conductscience.org/library/papers/22932727 | PubMed |
| 22,563,249 | Cardiac ryanodine receptor in metabolic syndrome: is JTV519 (K201) future therapy? | Diabetes Metab Syndr Obes | 2012 | https://conductscience.org/library/papers/22563249 | PubMed |
| 21,642,946 | Targeting ryanodine receptors for anti-arrhythmic therapy. | Acta Pharmacol Sin | 2011 | https://conductscience.org/library/papers/21642946 | PubMed |
1 to 10 of 17
See all 17 cited byGenes0
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
None in this release.
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/11090108
GET https://conductscience.org/api/papers/v1/11090108/references?page=2